Go Pro

Eyepoint Pharmaceuticals (EYPT) Institutional Ownership

Eyepoint Pharmaceuticals logo
$14.28 -0.44 (-2.99%)
Closing price 04:00 PM Eastern
Extended Trading
$14.54 +0.26 (+1.79%)
As of 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Eyepoint Pharmaceuticals (NASDAQ:EYPT)

Current
Institutional Ownership
Percentage
99.41%
Number of
Institutional Buyers
(last 12 months)
95
Total
Institutional Inflows
(last 12 months)
$503.46M
Number of
Institutional Sellers
(last 12 months)
48
Total
Institutional Outflows
(last 12 months)
$111.48M
Get EYPT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Eyepoint Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

EYPT Institutional Buying and Selling by Quarter

Eyepoint Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026Bank of America Corp DE383,443$4.94M0.0%-7.8%0.457%
5/19/2026Stempoint Capital LP810,764$10.45M2.0%+129.1%0.967%
5/19/2026Janus Henderson Group PLC3,601,168$46.42M0.0%+22.6%4.295%
5/18/2026California State Teachers Retirement System105,101$1.36M0.0%+2,158.3%0.125%
5/18/2026Royal Bank of Canada11,418$147K0.0%-40.1%0.014%
5/16/2026The Manufacturers Life Insurance Company 36,072$465K0.0%+58.4%0.043%
5/16/2026Orbimed Advisors LLC1,069,147$13.78M0.3%-56.7%1.275%
5/15/2026Commodore Capital LP2,825,000$36.41M2.1%N/A3.370%
5/15/2026Granahan Investment Management LLC297,108$3.83M0.2%-19.0%0.354%
5/14/2026Renaissance Technologies LLC117,300$1.51M0.0%+90.4%0.140%
5/14/2026Sei Investments Co.50,506$651K0.0%+75.2%0.060%
5/14/2026Walleye Capital LLC300,184$3.87M0.0%N/A0.358%
5/13/2026Levin Capital Strategies L.P.31,500$406K0.0%+65.8%0.038%
5/7/2026Dimensional Fund Advisors LP401,121$5.17M0.0%-0.2%0.479%
5/7/2026KBC Group NV2,266$29K0.0%N/A0.003%
5/7/2026Swiss National Bank147,400$1.90M0.0%N/A0.176%
5/5/2026Bank of New York Mellon Corp255,381$3.29M0.0%-0.5%0.305%
4/30/2026Hsbc Holdings PLC833,455$10.74M0.0%N/A0.995%
4/27/2026Simplify Asset Management Inc.326,142$4.20M0.1%-13.1%0.391%
4/22/2026Janney Montgomery Scott LLC30,315$391K0.0%+14.8%0.036%
4/22/2026Pictet Asset Management Holding SA10,962$141K0.0%N/A0.013%
4/22/2026Sterling Capital Management LLC2,568$33K0.0%-41.0%0.003%
2/19/2026Invesco Ltd.339,004$6.19M0.0%+16.6%0.409%
2/18/2026Virtus Investment Advisers LLC16,638$304K0.1%+29.5%0.020%
2/18/2026Wellington Management Group LLP188,199$3.44M0.0%-12.6%0.227%
2/18/2026Susquehanna Portfolio Strategies LLC74,944$1.37M0.0%+22.5%0.091%
2/18/2026Susquehanna Fundamental Investments LLC87,245$1.59M0.1%-34.3%0.105%
2/18/2026Suvretta Capital Management LLC7,827,685$143.01M2.9%+26.4%9.455%
2/18/2026Orbimed Advisors LLC2,468,314$45.10M1.0%+37.4%2.981%
2/18/2026Janus Henderson Group PLC2,937,729$53.66M0.0%N/A3.548%
2/18/2026Cormorant Asset Management LP8,265,000$151.00M7.0%-0.7%9.983%
2/18/2026Artia Global Partners LP767,098$14.02M1.9%+22.1%0.927%
2/18/2026Balyasny Asset Management L.P.595,392$10.88M0.0%-21.3%0.719%
2/17/2026Guggenheim Capital LLC14,319$262K0.0%N/A0.017%
2/17/2026Schonfeld Strategic Advisors LLC661,452$12.09M0.1%N/A0.799%
2/17/2026Burkehill Global Management LP115,000$2.10M0.1%N/A0.139%
2/17/2026AQR Capital Management LLC12,127$222K0.0%N/A0.015%
2/17/2026Paradigm Biocapital Advisors LP3,691,475$67.44M1.7%+84.1%4.459%
2/17/2026Price T Rowe Associates Inc. MD92,570$1.69M0.0%+13.0%0.112%
2/17/2026Rock Springs Capital Management LP258,739$4.73M0.2%+717.4%0.313%
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
2/17/2026Osaic Holdings Inc.25,913$473K0.0%+699.8%0.031%
2/17/2026Integral Health Asset Management LLC200,000$3.65M0.2%N/A0.242%
2/17/2026Adage Capital Partners GP L.L.C.4,700,000$85.87M0.1%-15.5%5.677%
2/17/2026California State Teachers Retirement System4,654$85K0.0%+20.6%0.006%
2/17/2026Granahan Investment Management LLC366,675$6.70M0.3%+5.4%0.443%
2/17/2026State of Wisconsin Investment Board60,317$1.10M0.0%-22.2%0.073%
2/17/2026ExodusPoint Capital Management LP544,077$9.94M0.1%N/A0.657%
2/17/2026Royal Bank of Canada19,047$348K0.0%-92.6%0.023%
2/17/2026Persistent Asset Partners Ltd5,387$98K0.0%N/A0.007%
2/16/2026Spruce Street Capital LP981,543$17.93M5.9%N/A1.186%
2/16/2026Verition Fund Management LLC15,057$275K0.0%N/A0.018%
2/16/2026Panagora Asset Management Inc.132,214$2.42M0.0%+15.7%0.160%
2/16/2026Landscape Capital Management L.L.C.12,546$229K0.0%N/A0.015%
2/16/2026Barclays PLC140,726$2.57M0.0%+35.7%0.170%
2/13/2026The Manufacturers Life Insurance Company 22,775$416K0.0%+13.5%0.028%
2/13/2026Bleichroeder LP316,515$5.78M1.0%+23.4%0.382%
2/13/2026Schroder Investment Management Group168,382$3.01M0.0%-32.0%0.203%
2/13/2026Essex Investment Management Co. LLC124,956$2.28M0.3%-2.2%0.151%
2/13/2026Rafferty Asset Management LLC13,983$255K0.0%N/A0.017%
2/13/2026Alyeska Investment Group L.P.784,403$14.33M0.0%+289.6%0.947%
2/13/2026Charles Schwab Investment Management Inc.648,565$11.85M0.0%+22.0%0.783%
2/13/2026Police & Firemen s Retirement System of New Jersey20,073$367K0.0%+20.8%0.024%
2/13/2026State Street Corp1,834,850$33.52M0.0%+24.5%2.216%
2/13/2026Wells Fargo & Company MN88,286$1.61M0.0%-34.0%0.107%
2/12/2026MetLife Investment Management LLC41,799$764K0.0%+5.2%0.050%
2/12/2026Renaissance Technologies LLC61,600$1.13M0.0%N/A0.074%
2/12/2026Dimensional Fund Advisors LP402,063$7.34M0.0%+75.5%0.486%
2/12/2026Federated Hermes Inc.6,017,433$109.94M0.2%+36.3%7.268%
2/12/2026Marex Group plc47,777$873K0.0%N/A0.058%
2/12/2026Patient Square Capital LP780,000$14.25M3.1%-22.9%0.942%
2/12/2026Rosalind Advisors Inc.690,000$12.61M4.6%+6.2%0.833%
2/12/2026New York State Common Retirement Fund18,714$342K0.0%+53.2%0.023%
2/12/2026Nuveen LLC181,256$3.31M0.0%+73.1%0.219%
2/11/2026Janney Montgomery Scott LLC26,415$483K0.0%+87.4%0.032%
2/11/2026Deutsche Bank AG226,770$4.14M0.0%-36.3%0.274%
2/11/2026Franklin Resources Inc.4,976,915$90.93M0.0%+19.3%6.012%
2/11/2026RWC Asset Management LLP17,235$315K0.0%+6.4%0.021%
2/11/2026MCF Advisors LLC14,921$273K0.0%+8.3%0.018%
2/10/2026Goldman Sachs Group Inc.1,249,757$22.83M0.0%-17.5%1.510%
2/10/2026SBI Okasan Asset Management Co.Ltd.33,600$612K0.0%N/A0.041%
2/9/2026Geode Capital Management LLC1,899,367$34.71M0.0%+24.6%2.294%
2/9/2026Blue Owl Capital Holdings LP392,594$7.17M0.5%+6.8%0.474%
2/9/2026Simplify Asset Management Inc.375,264$6.86M0.1%+314.9%0.453%
2/6/2026Legato Capital Management LLC40,431$739K0.1%+9.3%0.049%
2/6/2026 PSP Research LLC29,530$540K0.5%N/A0.036%
2/6/2026ProShare Advisors LLC17,443$319K0.0%+39.7%0.021%
2/2/2026Oppenheimer & Co. Inc.10,806$197K0.0%N/A0.013%
1/30/2026Levin Capital Strategies L.P.19,000$347K0.0%-34.5%0.023%
1/29/2026UBS Group AG188,651$3.45M0.0%-46.1%0.228%
1/29/2026Vanguard Group Inc.4,822,139$88.10M0.0%+27.1%5.825%
PH: Do THESE 4 things to your bank account now … (Ad)

In a few short months, the US government could gain unprecedented powers over personal bank accounts - including the ability to track every transaction or freeze funds. Martin D. Weiss, PhD, founder of Weiss Ratings, has identified 4 simple steps Americans can take today to help safeguard their savings before any changes take effect.tc pixel

Discover all 4 steps to help protect your bank account now
1/29/2026China Universal Asset Management Co. Ltd.29,490$539K0.0%+33.5%0.036%
1/26/2026Mirae Asset Global Investments Co. Ltd.4,023$74K0.0%+51.0%0.005%
1/16/2026Aberdeen Group plc1,605,984$29.34M0.0%+101.6%1.940%
1/15/2026Nisa Investment Advisors LLC42,655$779K0.0%+31.2%0.052%
1/9/2026SG Americas Securities LLC11,200$205K0.0%-32.1%0.014%
1/7/2026Cyndeo Wealth Partners LLC22,990$420K0.0%+3.4%0.028%
1/1/2026JPMorgan Chase & Co.30,262$431K0.0%-87.8%0.037%
11/17/2025Woodline Partners LP100,263$1.43M0.0%-80.0%0.121%
11/17/2025Alyeska Investment Group L.P.201,348$2.87M0.0%-42.7%0.243%
11/17/2025Paradigm Biocapital Advisors LP2,005,365$28.56M0.8%N/A2.422%


EYPT Institutional Ownership - Frequently Asked Questions

During the previous two years, 162 institutional investors and hedge funds held shares of Eyepoint Pharmaceuticals. The most heavily invested institutionals were Cormorant Asset Management LP ($151.00M), Suvretta Capital Management LLC ($143.01M), Federated Hermes Inc. ($109.94M), Franklin Resources Inc. ($90.93M), Vanguard Group Inc. ($88.10M), Adage Capital Partners GP L.L.C. ($85.87M), and Paradigm Biocapital Advisors LP ($67.44M).Learn more on Eyepoint Pharmaceuticals' institutional investors.

99.41% of Eyepoint Pharmaceuticals' stock is owned by institutional investors. Learn more on EYPT's institutional investor holdings.

Of the 143 institutional investors that purchased Eyepoint Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Federated Hermes Inc. ($4.28M), Paradigm Biocapital Advisors LP ($3.69M), Janus Henderson Group PLC ($3.60M), Suvretta Capital Management LLC ($3.24M), RA Capital Management L.P. ($3.18M), Adage Capital Partners GP L.L.C. ($3.01M), and Commodore Capital LP ($2.83M).

Institutional investors have bought a total of 32,301,254 shares in the last 24 months. This purchase volume represents approximately $503.46M in transactions.

Of the 48 institutional investors that sold Eyepoint Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Orbimed Advisors LLC ($1.40M), Adage Capital Partners GP L.L.C. ($859.78K), Patient Square Capital LP ($701.98K), Suvretta Capital Management LLC ($611.38K), JPMorgan Chase & Co. ($582.23K), Woodline Partners LP ($400.07K), and Goldman Sachs Group Inc. ($264.85K).

Institutional investors have sold a total of 7,477,478 shares in the last 24 months. This volume of shares sold represents approximately $111.48M in transactions.



This page (NASDAQ:EYPT) was last updated on 7/13/2026 by MarketBeat.com Staff.
From Our Partners